Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Alder Biopharmaceuticals, Inc.

Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. The company was founded by Randall C. Schatzman, John A. Latham, and Mark J. Litton in 2004. The CEO is Dr. Randy Schatzman. Alder went public in May 2014.

Their best known drug is the monoclonal antibody eptinezumab, which is now in its second phase III trial for migraine prevention. They have a second monoclonal antibody drug for migraine, ALD-1910, currently in pre-clinical development. Alder licensed clazakizumab, previously ALD-518, an anti-IL-6 monoclonal antibody to Vitaeris, Inc. for worldwide marketing.

Investment goal date:
Dividends reinvested
Alder Biopharmaceuticals, Inc. ALDR report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-26
--
--
Q2 2017
2017-08-08
-1.4800
-1.4800
Q1 2017
2017-04-27
-1.9900
-1.9900
Q4 2016
2017-02-23
-0.9700
-0.9700
Q3 2016
2016-10-27
-0.7000
-0.7000
Q2 2016
2016-07-26
-0.7900
-0.7900
Q1 2016
2016-04-28
-0.7600
-0.7600
Q4 2015
2016-02-23
-0.6000
-0.6000
Q3 2015
2015-11-05
-0.6200
-0.6200
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ALLIANCEBERNSTEIN L.P.
1429799
BlackRock Fund Advisors
2133222
BlackRock Inc.
3956052
BlackRock Institutional Trust Company, N.A.
1248310
Cormorant Asset Management, LLC
1098205
EAGLE ASSET MANAGEMENT INC
1155265
FMR LLC
7476984
Foresite Capital Management II, LLC
956041
JANUS CAPITAL MANAGEMENT LLC
5167085
Partner Fund Management, L.P.
1045181
Redmile Group, LLC
1909886
STATE STREET CORP
1777113
TPG Group Holdings (SBS) Advisors, Inc.
1238533
Vanguard Group, Inc
3438702
WELLINGTON MANAGEMENT CO LLP
3640788
Major Shareholders
Name Relationship
Total Shares
Holding stocks
DOW STEPHEN M
1.0000% (307190)
ALDR / CTXS / CYTK /
JAGGERS JOHN V
0.0100% (4458)
ALDR / CPST /
SIEGALL CLAY B
0.0100% (4444)
ALDR / SGEN /
SIEGALL CLAY B
0.1000% (31714)
ALDR / SGEN /
YARNO WENDY L
0.0200% (5000)
PAKIANATHAN DEEPIKA
9.2100% (2838532)
Montgomery Alan Bruce
0.0300% (9628)
ALDR / XNCR /
Novo A/S
10.3900% (3201183)
Delphi Management Partners VII, L.L.C.
9.2100% (2838532)
ALDR /
TPG Group Holdings (SBS) Advisors, Inc.
8.0800% (2488533)
Davidson Aaron
1.6800% (516395)
ALDR / OCRX /
Ventures West 8 Limited Partnership
11.2600% (3469528)
ALDR /
Schatzman Randall C
0.3700% (115172)
ALDR /
Benedict Larry
0.1000% (30989)
ALDR /
Litton Mark James
0.3200% (99932)
ALDR /
Latham John A
0.8200% (252200)
ALDR /
% ()